Page last updated: 2024-08-22

doxifluridine and Carcinoma, Papillary

doxifluridine has been researched along with Carcinoma, Papillary in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukami, Y; Hasegawa, H; Hiromatsu, T; Itazu, K; Kawai, K; Komatsu, S; Sakamoto, E; Tabata, T1
Kuribayashi, H; Nishibe, M; Nishihara, H; Sato, T; Watanabe, I1
Kawasaki, K; Kishibuchi, M; Nishi, T; Yagyu, T; Yamasaki, M; Yasui, M; Yayoi, E1
Katoh, T; Kawahara, T; Kobayakawa, K; Takatsuka, Y; Tsumura, I1

Other Studies

4 other study(ies) available for doxifluridine and Carcinoma, Papillary

ArticleYear
[A case of recurrent breast cancer with multiple lung, adrenal, inferior vena cava tumor thrombus and bone metastases successfully treated with 5'-DFUR and hormonal therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Follow-Up Studies; Humans; Leuprolide; Lung Neoplasms; Mastectomy, Radical; Neoplastic Cells, Circulating; Tamoxifen; Vena Cava, Inferior

2005
[A case of advanced breast cancer receiving combination therapy with 5'-DFUR and MPA with remarkable results].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Drug Administration Schedule; Female; Floxuridine; Humans; Lymph Node Excision; Lymphatic Metastasis; Medroxyprogesterone Acetate

1997
[A case of intra-arterial infusion chemotherapy for liver metastases of breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:12

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone; Middle Aged

1999
[Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pleural Neoplasms; Soft Tissue Neoplasms

1992